Veradermics MANE
NYSE MANE
$117.11 -4.12 (-3.40%)
As of: Oct 1, 2026 · 3:59 PM EDT

Veradermics (MANE) Net Equity Issued and Repurchased (2025 - 2026)

Updated

Veradermics' Net Equity Issued and Repurchased came in at $145.23 million for Q2 2026, compared with $129,000 a year earlier and down 46.0% from the prior quarter.

Analysis

Veradermics (MANE) Net Equity Issued and Repurchased (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Veradermics reported Net Equity Issued and Repurchased of $414.46 million; for FY2025, it came in at $156,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Veradermics 5.07 Bn 5.07 Bn - 145.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 145.23 Mn
Mar 31, 2026 269.10 Mn
Jun 30, 2025 129,000.00
API Access

Veradermics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=MANE&period=max&api_key=YOUR_API_KEY